Clinical Efficacy of Remdesivir and Favipiravir in the Treatment of Covid-19 Patients: Scenario So Far. (Record no. 6808)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01924nam a22003017a 4500 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 211101s20212021 xxu||||| |||| 00| 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 2589-9775 |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | Ovid MEDLINE(R) |
| 099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC) | |
| PMID | 34365935 |
| 245 ## - TITLE STATEMENT | |
| Title | Clinical Efficacy of Remdesivir and Favipiravir in the Treatment of Covid-19 Patients: Scenario So Far. |
| 251 ## - Source | |
| Source | Current Drug Research Reviews. 2021 Aug 06 |
| 252 ## - Abbreviated Source | |
| Abbreviated source | Curr Drug Res Rev. 2021 Aug 06 |
| 253 ## - Journal Name | |
| Journal name | Current drug research reviews |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Year | 2021 |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Manufacturer | FY2022 |
| 265 ## - SOURCE FOR ACQUISITION/SUBSCRIPTION ADDRESS [OBSOLETE] | |
| Publication status | aheadofprint |
| 266 ## - Date added to catalog | |
| Date added to catalog | 2021-11-01 |
| 520 ## - SUMMARY, ETC. | |
| Abstract | The novel SARS-CoV-2 is a new disease that has caused severe destruction to human lives across the globe, including infection, mortality and financial crises, for which, scientific researchers have been directed towards the development of treatment and controlling measures against coronavirus. Currently, there has been no approved drug for the treatment of the disease, but several antiviral drugs have shown therapeutic effects from which, remdesivir and favipiravir are two such drugs. These drugs have shown some therapeutic potential in the treatment of COVID-19 by inhibiting viral enzyme RNA-dependent RNA polymerase. The purpose of this systematic review is to provide an overview of the effectiveness of these two drugs based on the clinical trials reported in current published data. Copyright(c) Bentham Science Publishers; For any queries, please email at [email protected]. |
| 546 ## - LANGUAGE NOTE | |
| Language note | English |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | IN PROCESS -- NOT YET INDEXED |
| 651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME | |
| Institution | MedStar Southern Maryland Hospital Center |
| 656 ## - INDEX TERM--OCCUPATION | |
| Department | Hospitalist |
| 657 ## - INDEX TERM--FUNCTION | |
| Medline publication type | Journal Article |
| 700 ## - ADDED ENTRY--PERSONAL NAME | |
| Local Authors | Chidurala, Ram Mohan |
| 790 ## - Authors | |
| All authors | Bhatti K, Chidurala RM, Das R, Mehta DK, Rana M, Saini M |
| 856 ## - ELECTRONIC LOCATION AND ACCESS | |
| DOI | <a href="https://dx.doi.org/10.2174/2589977513666210806122901">https://dx.doi.org/10.2174/2589977513666210806122901</a> |
| Public note | https://dx.doi.org/10.2174/2589977513666210806122901 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Koha item type | Journal Article |
| Item type description | Article |
| Withdrawn status | Lost status | Damaged status | Not for loan | Collection | Home library | Current library | Date acquired | Total Checkouts | Full call number | Barcode | Date last seen | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/01/2021 | 34365935 | 34365935 | 11/01/2021 | 11/01/2021 | Journal Article |